Advertisement

The Scientist

» industry, culture and developmental biology

Most Recent

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Book Excerpt from <em>Faith vs. Fact</em>

Book Excerpt from Faith vs. Fact

By | July 1, 2015

In Chapter 1, “The Problem,” author Jerry Coyne sets the historical stage for his suggestion that science and religion are not compatible and never will be.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | July 1, 2015

Stoned, Anxious, The Deeper Genome, and Testosterone

0 Comments

image: Speaking of Science

Speaking of Science

By | July 1, 2015

July 2015's selection of notable quotes

4 Comments

image: Staying Active in the Lab

Staying Active in the Lab

By | July 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

8 Comments

image: The War Rages On

The War Rages On

By | July 1, 2015

Conflict between science and religion continues, with effects on health, politics, and the environment.

4 Comments

image: Keeping Science Pubs Clean

Keeping Science Pubs Clean

By | June 29, 2015

Science releases new guidelines for research transparency, hoping to stem the tide of retractions and misconduct.

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

Popular Now

  1. Staying Active in the Lab
    Careers Staying Active in the Lab

    Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

  2. When Does a Smart Mouse Become Human?
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. Antibiotic Resistance Can Boost Bacterial Fitness
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist